TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/15/24 19:02 | 4/11/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | M.d | 50 | 2.48 | 0 | 20 | 0 | D | |||||||||||||||
4/15/24 19:02 | 4/11/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | S.d | -501 | 25.07 | 0 | -20 | -100 | 0 | D | ||||||||||||||
12/15/20 12:00 | 12/11/20 | FPRX | Five Prime Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 22 | 35 | 86 | D | ||||||||||||||
11/13/20 12:25 | 11/11/20 | FPRX | Five Prime Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 22 | 41 | 75 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |